How much will the Drug And Gene Delivery Devices industry be worth in the Future????



The global drug and gene delivery systems market is expected to reach USD 786.9 Billion by 2025, according to a new report by Grand View Research, Inc. Rising investment by the market players to develop innovative drug delivery systems to cater to the demand by the patients as well as to increase the bioavailability at minimum quantity of active pharmaceutical ingredient is driving the market growth. Additionally, increasing focus on R&D of gene delivery systems owing to the high growth potential of gene therapy for the treatment of a wide range of diseases is expected to fuel the market growth in the future.
Unavailability of targeted therapy for CoVid-19 is forcing healthcare professionals to provide symptom-based treatment to patients. This includes a wide range of treatment options based on factors such as patient type, symptoms, and drug availability. Currently, major drugs used in the treatment of CoVid19 include Chloroquine, Hydroxychloroquine, Remdesivir, Lopinavir, Azithromycin, and Tocilizumab. Most of these drugs are available as tablets and capsules. In countries with the presence of pharmaceutical manufacturing giants, the market is expected to witness a sudden surge in the upcoming weeks. We are working to account for this surge in our estimates. The report will account for Covid-19 as a key market contributor.
Drug delivery systems are in a constant evolution along with the changing preference by the patient. For instance, initially, hormone replacement therapy was widely prescribed in the form of pills, whereas, it is now available in the form of prefilled syringes, patches, vaginal rings, gel, and sprays. The principal purpose of development of different forms of delivery systems is to increase the ease of use. Factors such as aesthetics of the delivery systems, price, and amount of API are also considered while designing the drug delivery system.
To Request Sample Copy of this report, click the link:
https://www.grandviewresearch.com/industry-analysis/drug-gene-delivery-devices-market/request/rs2
Major players in the drug delivery systems market include but are not limited to Pfizer, Inc., F. Hoffmann-La Roche Ltd, Johnson and Johnson Private Ltd, Novartis AG, Bayer AG, and Becton, Dickinson and Company. These companies are constantly investing in the product development to cater to the changing demands of the patients and to maintain their position in the competition.
Key players operating in the gene delivery systems include Uniqure N.V., SiBiono GeneTech Co., Epeius Biotechnologies Corporation, Shanghai Sunway Biotech Co., Ltd, and Human Stem Cells Institute. These companies are also engaged in the R&D of their products to explore further applications in the different physiological conditions.
Further key findings from the study suggest:
·         The market study suggests that oral segment dominated the market in 2015
·         The convenience of use and low manufacturing cost are the prime factors responsible for the dominance of the oral delivery segment
·         Injectable segment is expected to show a lucrative growth rate owing to the introduction of technically advanced injecting devices that enable convenient self-injection
·         North America dominated the market in 2015 and is expected to remain dominant throughout the forecast period owing to highly developed healthcare infrastructure and high healthcare spending
·         Asia pacific is expected to exhibit the fastest growth rate during the forecast period owing to the factors such as rapidly developing economies, growing disposable income, and high adaption of the advanced delivery systems
·         A few of the major market players in drug delivery systems space are F. Hoffmann-La Roche Ltd, Pfizer, Inc., Johnson and Johnson private Ltd, Novartis AG, Becton, Dickinson and Company, and Bayer AG.
·         Major market players in the gene delivery systems space are SiBiono GeneTech Co., Unique N.V., Epeius Biotechnologies Corporation, Human Stem Cells Institute, and Shanghai Sunway Biotech Co., Ltd.
The global drug and gene delivery system market size was valued at USD 379.2 Billion in 2015. Growing efforts towards formulating dosage forms that would help in maximizing the bioavailability of the drug at the target site while increasing the patient convenience are driving the global market growth. The introduction of the novel drug delivery systems such as subdermal implants that are available in different forms such as rings and patches are expected to aid in the industry growth.
The evolution of the drug delivery systems is directly attributed to changing preferences by patients as well as healthcare professionals. A few of the many advancements include-
     • Introduction of Biopharmaceutical classification systems (BCS) class II drug in oral dosage forms
     • Introduction of auto-injectors
     • Availability of advanced implants in customized shapes and sizes
     • Introduction of advanced pulmonary devices such as Smartcard and Adaptive Aerosol Delivery
Based on the route of administration, the report is segmented into oral, inhalation, transdermal, injectable, ocular, nasal, and topical. Oral segment captured the largest share in 2015. Pharmaceutical companies are focusing on reducing the amount of API per dose and increase the bioavailability at the site of action.
Browse Press Release of this report:
https://www.grandviewresearch.com/press-release/global-drug-gene-delivery-devices-market
The potency and safety of biotechnology agents are attracting the biopharmaceutical companies to invest largely in research and development of these drugs. These biological drugs are rapidly replacing their traditional counterparts and most of the them are prone to deterioration by oral route; thus injectable drug delivery is a preferred route of administration. Additionally, the advancements in injectable devices which enable the convenient self-injection by the patients are some of the factors expected to fuel the growth of the injectable segment during the forecast period.
Grand View Research has segmented the drug and gene delivery systems market on the basis of route of administration, vectors, methods:
Route of Administration Outlook (Revenue, USD Billion, 2014 - 2025)
·         Oral
·         Inhalation
·         Transdermal
·         Injectable
·         Ocular
·         Nasal
·         Topical
Vector Outlook (Revenue, USD Million, 2014 - 2025)
·         Viral
·         Non-viral
Method Outlook (Revenue, USD Million, 2014 - 2025)
·         In situ
·         Ex vivo
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.



Comments

Post a Comment

Popular posts from this blog

Foot Orthotic Insoles Market 2026: What Will Be Changes In Investment Ratio With Opportunity Analysis?? |Grand View Research, Inc.

Image
The global foot orthotic insoles market size is expected to reach USD 5.5 billion by 2026 , according to a new report by Grand View Research, Inc., exhibiting a 6.3% CAGR during the forecast period. Growing incidence of diabetes and plantar fasciitis are expected to drive the market over the forecast period. Moreover, rapid urbanization and increasing disposable income are anticipated to propel growth in future. Technological advancements, spurred by ongoing investments in R&D, are expected to increase growth potential in the coming years. Moreover, rise in geriatric population, which is susceptible to orthopedic disorders, is impelling product demand globally. For instance, in 2017 as per the U.S. Census Bureau, the number of people aged 65 or older increased by 1.6 million from 2014 to 2015. In addition, increasing incidence of sports injuries and rising prevalence of osteosarcoma in the region has led to the need for various orthotics devices, which is expected to drive ...
Read more

A Look into Smokehouse Industry……Deep Analysis…..

Image
The global smokehouse market size is anticipated to reach USD 157.2 million by 2025 , according to a new report by Grand View Research, Inc. The market is anticipated to register a CAGR of 2.2% during the forecast period. Rising need for a healthy lifestyle has led consumers to prefer griller or barbequed food over fried food and other kinds of fast food. This trend is expected to have a positive impact on the market growth. The home care & decor industry has been witnessing inconsistent growth, since the Covid 19 outbreak. As a result of the ongoing pandemic crisis, there has been a drop in the overall performance of discretionary products such as decorative fixtures, bedding products, to name a few. The virus outbreak has, however, led to substantial growth in categories such as cleaning and hygiene products. Prominent growth in the e-commerce business is also one of the positive influences of the outbreak, wherein companies are focusing on expanding their distribution ...
Read more

A Look into Shapewear Industry……Deep Analysis…..

Image
The global shapewear market size is expected to reach USD 3.80 billion by 2025 registering a CAGR of 7.7%, according to a new report by Grand View Research, Inc. The introduction of various products according to the type of garments is expected to support the market growth in the years to come. Growing target population across the globe is also augmenting the market growth. Changing lifestyle incurs increased investment in fitness and related accessories, which has positively impacted the market growth. The clothing, footwear, & accessories industry is anticipated to witness checkered growth throughout 2020, as a result of the unprecedented supply chain disruptions caused by the COVID-19 outbreak worldwide. The expected decline in the global sales of clothing, footwear, & accessories is attributable to massive supply chain disruptions across significant export markets, including China and India. However, the industry is likely to recover over the forecast timeframe,...
Read more